Onnit Labs New Mood Supplementation in Healthy College Students
- Conditions
- Mental Health Wellness 1
- Interventions
- Dietary Supplement: Multi-Ingredient Herbal SupplementDietary Supplement: Placebo Supplement
- Registration Number
- NCT05109923
- Lead Sponsor
- University of Idaho
- Brief Summary
The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan. 5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 56
- Currently enrolled collegiate men and women at the University of Idaho
- Currently taking mood or sleep enhancing supplementation/medication
- Currently participating in counseling and/or therapy sessions
- Previously diagnosed with a psychological disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description New Mood Supplementation Multi-Ingredient Herbal Supplement The New Mood herbal supplement includes lemon balm, 5-HPT, L-Tryptophan and valerian root. Placebo Supplementation Placebo Supplement The placebo includes rice bran and maltodextrin.
- Primary Outcome Measures
Name Time Method Change in resting heart rate (beats per minute) over 8 weeks Change from baseline resting heart rate (beats per minute) response at 8 weeks Manual radial pulse measurement of resting heart rate (beats per minute) at baseline and 8 weeks
Change in resting systolic and diastolic blood pressure (mm Hg) over 8 weeks Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks Digital sphygmomanometer measurement of resting systolic and diastolic blood pressure (mm Hg) at baseline and 8 weeks
Change in depression, anxiety and stress scores (0-34) over 8 weeks Change from baseline DASS-21 score at 8 weeks Depression, Anxiety and Stress Scale Questionnaire (DASS-21, 0-34) to assess depression, anxiety and stress scores from baseline to 8 weeks
Change in cortisol awakening response (mg/dL) over 8 weeks Change from baseline cortisol awakening response (mg/dL) at 8 weeks Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Idaho
🇺🇸Moscow, Idaho, United States